Lantheus Holdings Return on Equity

Lantheus Holdings (LNTH) currently reports a ROE of 23.02%. That is below the Healthcare sector average of 29.39%. Use the charts on this page to explore Lantheus Holdings's ROE history and peer comparisons.

Lantheus Holdings's ROE of 23.02% is lower than the Healthcare sector average of 29.39%. That is roughly 21.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Lantheus Holdings's current 23.02% should be judged against Healthcare norms (sector average: 29.39%) and against LNTH's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 23.02%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 29.39%. From there, open related valuation or income-statement pages for Lantheus Holdings, and consider following LNTH for alerts when major investors trade the stock.

Lantheus Holdings is classified in the Healthcare sector. On ROE, it currently shows 23.02% versus a sector average near 29.39%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LNTH with unrelated industries.